Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
12444 | 842 | 29.4 | 60% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MONOETHYLGLYCINEXYLIDIDE | Author keyword | 23 | 57% | 3% | 27 |
2 | MEGX | Author keyword | 20 | 63% | 2% | 20 |
3 | C 13 METHACETIN | Author keyword | 9 | 83% | 1% | 5 |
4 | QUANTITATIVE TESTING OF LIVER FUNCTION | Author keyword | 9 | 83% | 1% | 5 |
5 | AMINOPYRINE BREATH TEST | Author keyword | 9 | 47% | 2% | 14 |
6 | BREATH TEST | Author keyword | 6 | 11% | 6% | 53 |
7 | SORBITOL CLEARANCE | Author keyword | 6 | 71% | 1% | 5 |
8 | GALACTOSE ELIMINATION CAPACITY | Author keyword | 6 | 45% | 1% | 10 |
9 | MONOETHYLGLYCINEXYLIDIDE MEGX | Author keyword | 6 | 100% | 0% | 4 |
10 | ISOTOPE APPLICATION IN MEDICINE | Author keyword | 5 | 47% | 1% | 8 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | C 13 METHACETIN | 33 | 100% | 2% | 13 |
2 | GALACTOSE ELIMINATION CAPACITY | 30 | 56% | 4% | 36 |
3 | LIDOCAINE METABOLITE FORMATION | 25 | 77% | 2% | 17 |
4 | AMINOPYRINE BREATH TEST | 25 | 46% | 5% | 40 |
5 | LIDOCAINE METABOLISM | 18 | 49% | 3% | 26 |
6 | C 14 AMINOPYRINE | 15 | 71% | 1% | 12 |
7 | ELIMINATION CAPACITY | 15 | 73% | 1% | 11 |
8 | MONOETHYLGLYCINEXYLIDIDE | 13 | 47% | 2% | 21 |
9 | LIDOCAINE METABOLITE | 11 | 69% | 1% | 9 |
10 | MEGX TEST | 10 | 61% | 1% | 11 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Clinical Utility of C-13-Liver-Function Breath Tests for Assessment of Hepatic Function | 2013 | 11 | 54 | 72% |
Review article: breath testing for human liver function assessment | 2002 | 68 | 136 | 62% |
Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction | 2008 | 136 | 104 | 18% |
Review article: the assessment of liver function using breath tests | 2007 | 31 | 37 | 46% |
13C-breath tests for clinical investigation of liver mitochondrial function | 2010 | 10 | 37 | 43% |
C-13-breath tests: Current state of the art and future directions | 2007 | 50 | 130 | 29% |
QUANTITATIVE TESTS OF LIVER-FUNCTION | 1995 | 48 | 49 | 65% |
C-13-breath tests for the assessment of liver function | 2004 | 7 | 49 | 69% |
Antiarrhythmics: Elimination and dosage considerations in hepatic impairment | 2007 | 26 | 59 | 29% |
Potential use of pharmacological markers to quantitatively assess liver function during liver transplantation surgery | 2000 | 20 | 55 | 49% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | 3ITABASHI KU | 3 | 100% | 0.4% | 3 |
2 | INFRARED SCI TECHNOL GRP | 2 | 44% | 0.5% | 4 |
3 | POST GASTROENTEROL DIGEST ENDOSCOPY | 2 | 50% | 0.4% | 3 |
4 | GEN MED A | 1 | 50% | 0.2% | 2 |
5 | HVIDOVRE HOSP CLIN PHYSIOL | 1 | 50% | 0.2% | 2 |
6 | MED ENVIRONM HYG EPIDEMIOL | 1 | 100% | 0.2% | 2 |
7 | MED GEN A | 1 | 50% | 0.2% | 2 |
8 | CHAIRE MEDICAMENT GROSSESSE | 1 | 50% | 0.1% | 1 |
9 | CHAIRE MEDICAMENTS GROSSESSE | 1 | 50% | 0.1% | 1 |
10 | GASTROENTEROL HEPATOL NUTRIT | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000222717 | TRIMETHADIONE//ZAKLAD CHEM FIZJOL//ZAKLAD CHEM FIZJOLOGICZNEJ |
2 | 0.0000191521 | CYP1A2//CAFFEINE METABOLISM//CYP1A2 ACTIVITY |
3 | 0.0000147098 | PORTAL VEIN EMBOLIZATION//FUTURE LIVER REMNANT//ALPPS |
4 | 0.0000091945 | K M AND V MAX//PERFUSED MOUSE LIVER//N DESMETHYLDIAZEPAM |
5 | 0.0000082486 | BOF 4272//MULTIPLE INDICATOR DILUTION//HEPATIC ELIMINATION |
6 | 0.0000077742 | HEPATIC AMINO NITROGEN CONVERSION//UREA SYNTHESIS//AMMONIOGENESIS |
7 | 0.0000074187 | ARTERIAL KETONE BODY RATIO//HEPATIC MITOCHONDRIAL REDOX STATE//ARTERIAL KETONE BODY RATIO AKBR |
8 | 0.0000069298 | LIVER SPLEEN SCAN//GASTROENTEROL HEPATOLSECT HEPATOL//IMAN KHOMEINI HOSP COMPLEX |
9 | 0.0000062425 | MELD//MODEL FOR END STAGE LIVER DISEASE//DONOR RISK INDEX |
10 | 0.0000054495 | PER RECTAL PORTAL SCINTIGRAPHY//HEPATIC VEIN WAVEFORM//PORTAL VEIN VELOCITY |